Ocumetics Announces Scientific Advisory Committee to Support Advancing Clinical and Regulatory Strategy

   Calgary, Alberta – TheNewswire - February 26, 2026 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, today announced the formation of a Scientific Advisory Committee (SAC) to support the Company’s advancing clinical, regulatory, and commercialization strategy as it progresses toward late-stage development.The SAC will provide independent, multidisciplinary expertise across clinical trial design, regulato ...